Medicina interna
Especialidad
University of Washington School of Medicine
Seattle, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Washington School of Medicine (1)
2021
-
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
The Lancet Respiratory Medicine, Vol. 9, Núm. 12, pp. 1407-1418